2-amino-4',5-difluorobenzophenone | 5220-36-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-4',5-difluorobenzophenone
• 英文别名: (2-Amino-5-fluorophenyl)(4-fluorophenyl)methanone；(2-amino-5-fluorophenyl)-(4-fluorophenyl)methanone
• CAS: 5220-36-0
• 化学式: C₁₃H₉F₂NO
• 分子量: 233.217
• InChiKey: BSNFHXNLZZNMGF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-amino-4',5-difluorobenzophenone 在 cerium(III) chloride heptahydrate 、 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 16.38h， 生成 (E)-3-(3-(5,6-difluoro-1H-benzo[d]imidazol-2-yl)acryloyl)-6-fluoro-4-(4-fluorophenyl)quinolin-2(1H)-one
  参考文献：
  名称：

  Synthesis and SAR Studies of Dual AKT/NF-κB Inhibitors Against Melanoma

  摘要：

  The protein Kinase B alpha (AKT) and nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) pathways are central regulators of cellular signaling events at the basis of tumor development and progression. Both pathways are often up‐regulated in different tumor types including melanoma. We recently reported the identification of compound 1 (BI‐69A11) as inhibitor of the AKT and the NF‐κB pathways. Here, we describe SAR studies that led to novel fluorinated derivatives with increased cellular potency, reflected in efficient inhibition of AKT and IKKs. Selected compounds demonstrated effective toxicity on melanoma, breast, and prostate cell lines. Finally, a representative derivative showed promising efficacy in an in vivo melanoma xenograft model.

  DOI：

  10.1111/cbdd.12177

文献信息

• New Insight into the Central Benzodiazepine Receptor–Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4<i>H</i>-imidazo[1,5-<i>a</i>][1,4]benzodiazepines and Related Compounds
  作者：Maurizio Anzini、Salvatore Valenti、Carlo Braile、Andrea Cappelli、Salvatore Vomero、Stefano Alcaro、Francesco Ortuso、Luciana Marinelli、Vittorio Limongelli、Ettore Novellino、Laura Betti、Gino Giannaccini、Antonio Lucacchini、Simona Daniele、Claudia Martini、Carla Ghelardini、Lorenzo Di Cesare Mannelli、Gianluca Giorgi、Maria Paola Mascia、Giovanni Biggio

  DOI：10.1021/jm2001597

  日期：2011.8.25

  3-Substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds were synthesized as central benzodiazepine receptor (CBR) ligands. Most of the compounds showed high affinity for bovine and human CBR, their Ki values spanning from the low nanomolar to the submicromolar range. In particular, imidazoester 5f was able to promote a massive flow of 36Cl– in rat cerebrocortical synaptoneurosomes

  合成了3-取代的6-苯基-4 H-咪唑并[1,5- a ] [1,4]苯并二氮杂and和相关化合物作为中心苯并二氮杂receptor受体（CBR）配体。大多数化合物显示出对牛和人CBR的高亲和力，它们的K i值范围从低纳摩尔到亚微摩尔范围。特别是，imidazoester 5F是能够促进了大规模的流动36氯-在大鼠大脑皮层synaptoneurosomes与典型的完全激动剂的重叠其功效特征。化合物5f然后在小鼠中检查其药理作用，证明其是安全的抗焦虑药，没有经典的1,4-苯并二氮杂卓类药物的令人不悦的肌松和健忘作用。此外，一些选择的化合物的选择性已经评估了重组α 1 β 2 γ 2 L，α 2 β 1 γ 2 L，和α 5 β 2 γ 2大号人GABA甲受体。最后，将某些化合物连同Cromer GABA A同源性模型中的分子动力学模拟一起进行了分子对接计算。
• Antiinflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogs
  作者：David A. Walsh、H. Wayne Moran、Dwight A. Shamblee、Ibrahim M. Uwaydah、William J. Welstead、Lawrence F. Sancilio、Warren N. Dannenburg

  DOI：10.1021/jm00377a001

  日期：1984.11

  A series of substituted derivatives of 2-amino-3-benzoylphenylacetic acid (amfenac) has been synthesized and evaluated for antiinflammatory, analgesic, and cyclooxygenase inhibiting activity. Several derivatives including 157 (4'-chloro), 158 (4'-bromo), and 182 (5-chloro, 4'-bromo) were more potent than indomethacin in these assays.

  已经合成了一系列2-氨基-3-苯甲酰基苯基乙酸（氨苯乙酸）的取代衍生物，并评估了它们的抗炎，止痛和环加氧酶活性。在这些测定中，包括157（4'-氯），158（4'-溴）和182（5-氯，4'-溴）的几种衍生物比消炎痛更有效。
• Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(Substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors
  作者：D. R. Sliskovic、J. A. Picard、W. H. Roark、B. D. Roth、E. Ferguson、B. R. Krause、R. S. Newton、C. Sekerke、M. K. Shaw

  DOI：10.1021/jm00105a057

  日期：1991.1

  A series of substituted quinoline mevalonolactones were prepared and evaluated for their ability to inhibit the enzyme HMG-CoA reductase both in vitro and (cholesterol biosynthesis) in vivo. Since previous studies suggested that the 4-(4-fluorophenyl) and 2-(1-methylethyl) substituents afforded optimum potency, attention was focused on variations at position 6 of the quinoline ring. Biological evaluation

  制备了一系列取代的喹啉甲戊内酯，并评估了它们在体外和体内（胆固醇生物合成）抑制HMG-CoA还原酶的能力。由于先前的研究表明4-（4-氟苯基）和2-（1-甲基乙基）取代基具有最佳效价，因此将注意力集中在喹啉环的6位上。对带有多种6-取代基的少量类似物的生物学评估表明，在此位置进行修饰对效价影响很小。鉴定了几种化合物（8b，8e和11），它们在体外和体内试验中均显示出与Compactin和mevinolin相当的效价。
• 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
  申请人：A. H. Robins Company, Incorporated

  公开号：US04503073A1

  公开（公告）日：1985-03-05

  Novel 2-amino-3-(alkylthiobenzoyl)phenylacetic acids, esters and metal salts have the formula: ##STR1## wherein R is hydrogen or lower alkyl, R.sup.1 is hydrogen, lower alkyl or pharmaceutically acceptable metal cation, R.sup.2 is hydrogen, halogen, lower alkyl or lower alkoxy, Am is primary amino (--NH.sub.2), methylamino or dimethylamino. The compounds have anti-inflammatory activity; have effective analgesic activity, and inhibit blood platelet aggregation.

  新型2-氨基-3-(烷硫基苯甲酰)苯乙酸、酯和金属盐的化学式为：##STR1## 其中，R为氢或较低的烷基，R.sup.1为氢、较低的烷基或药用可接受的金属阳离子，R.sup.2为氢、卤素、较低的烷基或较低的烷氧基，Am为一级氨基(--NH.sub.2)、甲基氨基或二甲基氨基。这些化合物具有抗炎活性；具有有效的镇痛活性，并抑制血小板聚集。
• WALSH, D. A.;MORAN, H. W.;SHAMBLEE, D. A.;UWAYDAH, I. M.;WELSTEAD, W. J. +, J. MED. CHEM., 1984, 27, N 11, 1379-1388
  作者：WALSH, D. A.、MORAN, H. W.、SHAMBLEE, D. A.、UWAYDAH, I. M.、WELSTEAD, W. J. +

  DOI：——

  日期：——